US: AIHLF - Adcock Ingram Holdings Limited

Rentabilité sur six mois: 0%

Calendrier des promotions Adcock Ingram Holdings Limited


À propos de l'entreprise

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services.

plus de détails
The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women's health. The company also provides critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.

EBITDA 17.94
EV/EBITDA 0.6991
Industry Pharmaceuticals
P/BV 0.161
P/E 1.08
P/S 0.0994
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 127.25
Див.доход ао 172.18
Дивиденд ао 1.59
Сайт https://www.adcock.co.za
Цена ао 2.45
Число акций ао 0.15463 млрд
Changement de prix par jour: 0% (2.45)
Changement de prix par semaine: 0% (2.45)
Changement de prix par mois: 0% (2.45)
Changement de prix sur 3 mois: 0% (2.45)
Changement de prix sur six mois: 0% (2.45)
Changement de prix par an: 0% (2.45)
Evolution du prix sur 3 ans: -21.97% (3.14)
Evolution du prix sur 5 ans: -43.16% (4.31)
Evolution des prix sur 10 ans: 0% (2.45)
Evolution des prix depuis le début de l'année: 0% (2.45)

Sous-estimation

Nom Signification Grade
P/S 0.7119 10
P/BV 0.0703 10
P/E 8.43 9
EV/EBITDA 7.25 9
Total: 8.63

Efficacité

Nom Signification Grade
ROA, % 1.02 1
ROE, % 1.58 1
Total: 1.67

Dividendes

Nom Signification Grade
Div yield, % 166.72 10
DSI 0.8571 8.57
Total: 8.51

Devoir

Nom Signification Grade
Debt/EBITDA 3.55 3
Total: 5.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -92.9 0
Rentabilité Ebitda, % -92.56 0
Rentabilité EPS, % 20.99 4
Total: 0.8

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Andrew Gideon Hall CA (SA), BPharm CEO & Executive Director 1962 (63 année)
Ms. Dorette Neethling CFO & Executive Director 1974 (51 année)
Ms. Basadifeela Letsoalo Executive Director of Transformation & Human Capital and Executive Director 1963 (62 année)
R. Essa Corporate Finance Director
Mr. Mahlatse Phalafala Company Secretary & Head of Legal
Mr. Nkosinathi Mthethwa Public Affairs Executive
Mr. Ashley Pearce Dip. Pharm, BCom Managing Director of Prescription
Mr. Colin Sheen B.Tech., M.B.A., NDip Mktg, PDBA Managing Director of Hospital
Mr. Tobie Krige MBA Managing Director of Distribution
Mr. Azhar Kaka Head of Sales - Consumer Division

Adresse: South Africa, Midrand, 1 New Road - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.adcock.co.za